SMTL ID : 4qo4.1

co-crystal structure of MDM2 (17-111) with compound 16, {(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(1S)-1-(6-CYCLOPROPYLPYRIDIN-2-YL)PROPYL]-3-METHYL-2-OXOPIPERIDIN-3-YL}ACETIC ACID

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x 35S: {(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-(6-cyclopropylpyridin-2-yl)propyl]-3-methyl-2-oxopiperidin-3-yl}acetic acid(Non-covalent)

35S.1: 14 residues within 4Å: Chain A: L.39, F.40, L.42, G.43, Q.44, I.46, M.47, Y.52, F.71, V.78, K.79, H.81, I.84, Y.85 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.39, A:L.39, A:L.42, A:I.46, A:I.46, A:Y.52, A:V.78, A:V.78, A:I.84 Hydrogen bonds: A:V.78 Salt bridges: A:K.79, A:H.81 pi-Stacking: A:H.81 Halogen bonds: A:H.81

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yu, M. et al., Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 Interaction. ACS Med Chem Lett (2014)

Release Date

2014-07-16

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence